Merck Aktie WKN: 659990 / ISIN: DE0006599905

147,25EUR
+0,05EUR
+0,03%
08:05:13
Diese Aktie kaufen
Werbung

Merck Aktien News

01.04.21
Alpine 4 Holdings subsidiary Excel Fabrication wins $1.3M in construction services contracts in NW US (Proactiveinvestors)
14.04.21
FansUnite Entertainment sees record 1Q betting volume of C$28.3M as McBookie sales surge (Proactiveinvestors)
19.04.21
Gemfields takes year to date sales to $90.3m after first emerald sales in 2021 (Mining.com)
29.03.21
Valeo Pharma shares get a boost as it unveils deal with Novartis on two Health Canada approved asthma therapies (Proactiveinvestors)
31.03.21
The Wall Street Journal: Pfizer working on freeze-dried version of COVID-19 vaccine that doesn’t need ultracold storage (MarketWatch)
01.04.21
: Pfizer warns EU bureaucracy is holding back worldwide vaccine efforts (MarketWatch)
01.04.21
Coronavirus Update: Pfizer and BioNTech say their COVID-19 vaccine is safe and highly effective — including against South Africa variant (MarketWatch)
20.03.21
Dispatches from a Pandemic: ‘My pulse rate had shot up to 120 as I gasped my way into the ER’: Italy resumes AstraZeneca vaccine, and tightens lockdown (MarketWatch)
23.03.21
: U.S. health agency says AstraZeneca may have included ‘outdated information’ when it released COVID-19 vaccine trial data (MarketWatch)
23.03.21
: U.S. doubts hit AstraZeneca COVID-19 vaccine just as Europe resumes its rollout (MarketWatch)
23.03.21
Coronavirus Update: Global case tally for COVID-19 nears 124 million as U.S. health experts question AstraZeneca trial data (MarketWatch)
25.03.21
: AstraZeneca now says its COVID-19 vaccine is 76% effective (MarketWatch)
26.03.21
GlaxoSmithKline and Vir Biotech have submitted EUA request to FDA for COVID antibody treatment (MarketWatch)
02.04.21
Coronavirus Update: Global tally of COVID cases edges closer to 130 million, as Fauci says U.S. may not need AstraZeneca vaccine (MarketWatch)
06.04.21
: AstraZeneca vaccine linked to rare blood clots, EMA official tells newspaper (MarketWatch)
07.04.21
: EU and U.K. regulators say AstraZeneca vaccine is safe, but Brits under 30 to be offered alternative shot (MarketWatch)
08.04.21
: Europe’s vaccine woes continue as Spain and Italy halt use of AstraZeneca shot for under-60s (MarketWatch)
08.04.21
London Markets: Johnson Matthey leads FTSE after optimistic update, while AstraZeneca sees strength (MarketWatch)
09.04.21
Coronavirus Update: Global COVID-19 case tally above 134 million as more countries impose restrictions on AstraZeneca vaccine (MarketWatch)
13.04.21
: Moderna COVID-19 vaccine rollout begins in England, giving under 30s alternative to AstraZeneca (MarketWatch)
13.04.21
: This is no time to ‘prematurely declare victory’ in the battle against COVID-19, says Fauci (MarketWatch)
14.04.21
: Denmark becomes first country to permanently stop use of AstraZeneca vaccine (MarketWatch)
14.04.21
Coronavirus Update: Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine (MarketWatch)
15.04.21
London Markets: GlaxoSmithKline shares surge on report Elliott Management building a stake (MarketWatch)
16.04.21
: Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout (MarketWatch)
22.03.21
JJ Lin surprises fans with live streaming concert (EN, Chinapost)
24.03.21
Johnson & Johnson Announces Five Initiatives to Help Find the ‘Missing Millions’ of Undiagnosed People Living with Tuberculosis (EN, Johnson & Johnson)
26.03.21
Janssen Receives Positive CHMP Opinion for PONVORY™ (ponesimod) for the Treatment of Adults With Relapsing Forms of Multiple Sclerosis With Active Disease Defined by Clinical or Imaging Features (EN, Johnson & Johnson)
29.03.21
JJ Lin celebrates 40th birthday in style (EN, Chinapost)
29.03.21
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
31.03.21
Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing (EN, Johnson & Johnson)
02.04.21
Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents (EN, Johnson & Johnson)
04.04.21
Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing (Updated) (EN, Johnson & Johnson)
06.04.21
New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients (EN, Johnson & Johnson)
12.04.21
Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference (EN, Johnson & Johnson)
13.04.21
JJ Redick makes Dallas debut against former team in 76ers (EN, Chinapost)
13.04.21
US recommends 'pause' for JJ vaccine over clot reports (Korea Times)
13.04.21
Johnson & Johnson Statement on COVID-19 Vaccine (EN, Johnson & Johnson)
13.04.21
Johnson & Johnson Statement on COVID-19 Vaccine (Updated) (EN, Johnson & Johnson)
15.04.21
Johnson & Johnson Statement on CDC Advisory Committee Meeting on Company COVID-19 Vaccine (EN, Johnson & Johnson)
Seite: 123456789...14

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln